Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Hand Pocket Pal Tray DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1835-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1834-2019Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Handy Pocket Pal Club Pak DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1833-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1832-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Redness Relief Club Pack DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1831-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1830-2019Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Club Pack DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1829-2019Class IITerminatedAug 28, 2019Clear Eyes Assorted Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1828-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Redness and Itchy Eye Relief Sidekick DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1827-2019Class IITerminatedAug 28, 2019Clear Eyes Assorted IRC DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1826-2019Class IITerminatedAug 28, 2019Clear eyes MAXIMUM REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1825-2019Class IITerminatedAug 28, 2019Clear eyes MAXIMUM ITCHY EYE RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1824-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1823-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1822-2019Class IITerminatedAug 21, 2019Tamsulosin Hydrochloride CapsulesFailed Dissolution SpecificationsMacleods Pharma Usa Inc · D-1844-2019Class IITerminatedAug 21, 2019CarbamazepineFailed Dissolution SpecificationsAmerican Health Packaging · D-1821-2019Class IITerminatedAug 21, 2019Aspirin and Extended-release Dipyridamole CapsulesFailed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.American Health Packaging · D-1820-2019Class IITerminatedAug 21, 2019FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1819-2019Class IITerminatedAug 21, 2019VINCRISTINE 1 MG /50 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1818-2019Class IITerminatedAug 21, 2019VINBLASTINE 10.9 MG / 100 ML D5W IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1817-2019Class IITerminatedAug 21, 2019VELCADE 2.1 mg / 0.84 ml SQ SYRINGELack of Assurance of SterilityInfusion Options, Inc. · D-1816-2019Class IITerminatedAug 21, 2019TRASTUZUMAB 427 MG / 250 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1815-2019Class IITerminatedAug 21, 2019TOPOTECAN 1.24 MG / 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1814-2019Class IITerminatedAug 21, 2019SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1813-2019Class IITerminatedAug 21, 2019Sodium Chloride 0.9% 1 LITER WITH Potassium Chloride 20 mEqLack of Assurance of SterilityInfusion Options, Inc. · D-1812-2019Class IITerminatedAug 21, 2019RomiPLOStim 700 MCG/ 1.4 ML SQ SYRLack of Assurance of SterilityInfusion Options, Inc. · D-1811-2019Class IITerminatedAug 21, 2019RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1810-2019Class IITerminatedAug 21, 2019RITUXAN 728 MG QS 728 mL 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1809-2019Class IITerminatedAug 21, 2019REMICADE 680 MG QS 250 ML 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1808-2019Class IITerminatedAug 21, 2019RAMUCIRUMAB 457 MG QS 250 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1807-2019Class IITerminatedAug 21, 2019PRESERVATIVE FREE 0.9% NACL 5 ML SYRLack of Assurance of SterilityInfusion Options, Inc. · D-1806-2019Class IITerminatedAug 21, 2019PERTUZUMAB 840 MG/250 ml0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1805-2019Class IITerminatedAug 21, 2019PERJETA 420 MG/250 ml 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1804-2019Class IITerminatedAug 21, 2019PEMETREXED 910 MG QS 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1803-2019Class IITerminatedAug 21, 2019PANITUMUMAB 400 MG / 100 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1802-2019Class IITerminatedAug 21, 2019PEMBROLIZUMAB 200 MG / 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1801-2019Class IITerminatedAug 21, 2019PACLITAXEL PROTEIN 175 MG/100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1800-2019Class IITerminatedAug 21, 2019PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1799-2019Class IITerminatedAug 21, 2019PACLITAXEL 258 MG / 500 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1798-2019Class IITerminatedAug 21, 2019OXALIPLATIN 145 MG /250 ML D5W IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1797-2019